Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Texas Justices Fuel Confusion Over Abortion Ban Exceptions No Photo Available

Hannah Albarazi

The Texas Supreme Court recently ruled that doctors may perform abortions only when "reasonable medical judgment" says a patient's lif... (more story)

HHS Guidance, Feud Over FCA Evidence, And A Deposed AG No Photo Available

Theresa Schliep

States sue the Biden administration over nondiscrimination guidance. A False Claims Act case sees a tussle over evidence. A Connecticu... (more story)

What Clinical Trial Attys Want From FDA Diversity Guidance No Photo Available

Theresa Schliep

Impending federal guidance on diversifying clinical trial participation marks the latest push to address the historic homogeneity of c... (more story)